Biocharacteristics shared by highly protective vaccines against Marek's disease

Avian Pathology

Volumn 33, Issue 1, 2004, Pages 59-68

  Gimeno, Isabel M ^a   Witter, Richard L ^a   Hunt, Henry D ^a   Reddy, Sanjay M ^a,b   Reed, Willie M ^c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MAREK DISEASE VACCINE; VIRUS DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CHICKEN; COMPARATIVE STUDY; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PATHOGENICITY; SEROTYPING; STANDARD; VIRULENCE; VIRUS CULTURE; VIRUS REPLICATION;

ANIMALS; CHICKENS; DNA, VIRAL; FEMALE; HERPESVIRUS 2, GALLID; LYMPHOCYTE ACTIVATION; MALE; MAREK DISEASE; MAREK DISEASE VACCINES; POULTRY DISEASES; SEROTYPING; VACCINES, ATTENUATED; VIRULENCE; VIRUS CULTIVATION; VIRUS REPLICATION;

ANIMALIA; AVES; DNA VIRUSES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPETOVIRUS; MARDIVIRUS;

EID: 1642491786     PISSN: 03079457     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Baaten, B.J.G., Butter, C., Walter, E. & Davison, T.F. (2002). Marek's disease virus: infection by the natural route. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology (p. 38). Limassol, Cyprus.
2. Bacon, L.D. & Witter, R.L. (1993). Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Diseases, 37, 53-59.
3. Bacon, L.D. & Witter, R.L. (1994a). B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens. Poultry Science, 73, 481-487.
4. Bacon, L.D. & Witter, R.L. (1994b). Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Avian Diseases, 38, 65-71.
5. Bacon, L.D., Hunt, H.D. & Cheng, H.H. (2000). A review of the development of chicken lines to resolve genes determining resistance to diseases. Poultry Science, 79, 1082-1093.
6. Butter, C., Baaten, B.J.G. & Davison, T.F. (2002). The avian lung: a lymphoid organ with a crucial role in the pathogenesis of Marek's disease. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology (p. 37). Limassol, Cyprus.
7. Calnek, B.W., Schat, K.A., Ross, L.J.N., Shek, W.R. & Chen, C.L.H. (1984). Further characterization of Marek's disease virus infected lymphocytes. I. In vivo infection. International Journal of Cancer, 33, 389-398.
8. Calnek, B.W., Lucio, B., Schat, K.A. & Lillehoj, H.S. (1989). Pathogenesis of Marek's disease virus-induced local lesions. 1. Lesion characterization and cell line establishment. Avian Diseases, 33, 291-302.
9. Chan, M.L., Chen, C.L., Ager, L.L. & Cooper, M.D. (1988). Identification of the avian homologues of mammalian CD4 and CD8 antigens. Journal of Immunology, 140, 2133-2138.
10. Chen, C.L.H., Ager, L.L., Gartland, G.L. & Cooper, M.D. (1986). Identification of a T3/T cell receptor complex in chicken. Journal of Experimental Medicine, 164, 375-380.
11. Churchill, A.E., Chubb, R.C. & Baxendale, W. (1969). The attenuation with loss of oncogenicity of the herpes-type virus of Marek's disease (Strain HPRS-16) on passage in cell culture. Journal of General Virology, 4, 557-564.
12. de Boer, G.F., Groenendal, J.E., Boerrigter, H.M., Kok, G.L. & Pol, J.M.A. (1986). Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains. Avian Diseases, 30, 276-283.
13. Dudnikov, L.A. & Witter, R.L. (2001). A comparison of autologous and heterologous vaccination against Marek's Disease. Proceedings of the 6th International Symposium on Marek's disease. (pp. 249-255). Montreal, Canada.
14. Ewert, D.L., Munchus, M.S., Chen, C.L. & Cooper, M.D. (1984). Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants. Journal of Immunology, 132, 2524-2530.
15. Gobel, T., Chen, C., Shrimpf, J., Grossi, C., Bernot, A., Bucy, R., Auffray, C. & Cooper, M. (1994). Characterization of avian natural killer cells and their intracellular CD3 protein complex. European Journal of Immunology, 24, 1685-1691.
16. Hunt, H.D., Lupiani, B., Miller, M.M., Gimeno, I.M., Lee, L.F. & Parcells, M.S. (2001). Marek's disease virus down regulates surface expression of MHV (B complex) class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology, 282, 198-205.
17. Kost, R.G., Jones, D., Isfort, R.J., Witter, R.L. & Kung, H.J. (1992). Retrovirus insertion into herpesvirus: characterization of a Marek's disease virus harboring a solo LTR. Virology, 192, 161-169.
18. Kross, I. (1996). Isolation of highly lytic serotype 1 Marek's disease viruses from recent field outbreaks in Europe. In R.F. Silva, H.H. Cheng, P.M. Coussens, L.F. Lee & L.F Velicer (Eds.), Current Research on Marek's Disease (pp. 113-118). Kennett Square, PA: American Association of Avian Pathologists.
19. Moller, L.B., Kauffman, J., Verland, S., Salomonsen, J., Avila, D., Lambris, J.D. & Skjodt, K. (1991). Immunogenetics, 34, 110-120.
20. Nazerian, K., Witter, R.L., Lee, L.F. & Yanagida, N. (1996). Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Diseases, 40, 368-376.
21. Ohashi, K., Mikami, T., Kodama, H. & Izawa, H. (1987). Suppression of NK activity of spleen cells by chicken fetal antigen present on Marek's disease lymphoblastoid cell line cells. International Journal of Cancer, 40, 378-382.
22. Omar, A.R. & Schat, K.A. (1996). Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology, 222, 87-99.
23. Omar, A.R. & Schat, K.A. (1997). Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology, 90, 579-585.
24. Paramithiotis, E., Tkalec, L. & Ratcliffe, M.J.H. (1991). High levels of CD45 are coordinately expressed with CD4 and CD8 on avian thymocytes. Journal of Immunology, 147, 3710-3717.
25. Parcells, M.S., Lin, S.F., Dienglewicz, R.L., Majerciak, V., Robinson, D.R., Chen, H.C., Wu, Z., Dubyak, G.R., Brunovskis, P., Hunt, H.D., Lee, L.F. & Kung, H.J. (2001). Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): Characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV Journal of Virology, 75, 5159-5173.
26. Petherbridge, L., Howes, K., Baigent, S.J., Evans, S., Osterrieder, N. & Venugopal, K. (2002). Infectious bacterial artificial chromosome of Marek's disease virus vaccine strain CVI988: a novel approach for generation of molecularly defined vaccines. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology (p. 47). Limassol, Cyprus.
27. Reddy, S.M., Witter, R.L. & Gimeno, I.M. (2000). Development of a quantitative-competitive polymerase chain reaction assay for serotype 1 Marek's disease virus. Avian Diseases, 44, 770-775.
28. Reddy, S.M., Lupiani, B., Gimeno, I.M., Silva, R.F., Lee, L.F. & Witter, R.L. (2002). Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proceedings of the National Academy of Science, 99, 7054-7059.
29. Rispens, B.H., Van Vloten, J., Mastenbroek, N., Maas, H.J.L. & Schat, K.A. (1972). Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Diseases, 16, 108-125.
30. Schat, K.A., Calnek, B.W., Fabricant, J. & Graham, D.L. (1985). Pathogenesis of infection with attenuated Marek's disease virus strains. Avian Pathology, 14, 127-146.
31. Sevoian, M., Chamberlain, D.M. & Counter, F.T. (1962). Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms. Veterinary Medicine, 57, 500-501.
32. Sharma, J.M. (1981). Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Diseases, 25, 882-893.
33. Sharma, J.M. (1987). Embryo vaccination of chickens with turkey herpesvirus: characteristics of the target cell of early viral replication in embryonic lung. Avian Pathology, 16, 567-579.
34. Shek, W.R., Calnek, B.W., Schat, K.A. & Chen, C.L.H. (1983). Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. Journal of the National Cancer Institute, 70, 485-491.
35. Silva, R.F., Lupiani, B. & Reddy, S.M. (2002). The effect of deleting or inverting the 132 base pair repeats in a pathogenic MDV. Workshop on Molecular Pathogenesis of Marek's disease and Avian Immunology (p. 49). Limassol, Cyprus.
36. Tischer, B.K., Schumacher, D., Beer, M., Beyer, J., Teifke, J.P., Osterrieder, K., Zelnik, V., Fehler, F. & Osterrieder, N. (2002). Efficacy of a BAC DNA vaccine against Marek's disease. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology (p. 46). Limassol, Cyprus.
37. Tregaskes, C., Kong, F.K., Paramithiotis, E., Chen, C.L., Ratcliffe, M.J.H., Davison, T.F. & Young, J.R. (1995). Identification and analysis of the expression of CD8 alpha beta and CD8 alpha alpha isoforms in chickens reveals a major TCR-gamma delta CD8 alpha beta subset of intestinal intraepithelial lymphocytes. Journal of Immunology, 154, 4485.
38. Venugopal, K., Bland, A.P., Ross, L.J.N. & Payne, L.N. (1996). Pathogenicity of an unusual highly virulent Marek's disease virus isolated in the United Kingdom. In R.F Silva, H.H. Cheng, P.M. Coussens, L.F. Lee & L.F. Velicer (Eds.), Current Research on Marek's Disease (pp. 119-124). Kennett Square, PA: American Association of Avian Pathologists.
39. Veromaa, T., Vainio, O., Eerola, E. & Toivanen, A. (1988). Monoclonal antibodies against chicken Bu-1a and Bu-1b alloantigens. Hybridoma, 7, 41-48.
40. Witter, R.L. (1987). New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy. Avian Diseases, 31, 752-765.
41. Witter, R.L. (1991). Attenuated revenant serotype 1 Marek's disease viruses: safety and protective efficacy. Avian Diseases, 35, 877-891.
42. Witter, R.L. (1997). Increased virulence of Marek's disease virus field isolates. Avian Diseases, 41, 149-163.
43. Witter, R.L. (2001). Protective efficacy of Marek's disease vaccines. In K. Hirai (Ed.), Current Topics in Microbiology and Immunology (pp. 58-90). Berlin: Springer-Verlag.
44. Witter, R.L. (2002). Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses. Avian Diseases, 46, 925-937.
45. Witter, R.L. & Lee, L.F (1984). Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathology, 13, 75-92.
46. Witter, R.L., Lee, L.F. & Fadly, A.M. (1995). Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus. Avian Diseases, 39, 269-284.
47. Witter, R.L., Li, D., Jones, D., Lee, L.F. & Kung, H.J. (1997). Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Diseases, 41, 407-421.